🔎 Trials Near Me

Akèy › Kansè Ezofajyen › Arizona › Tucson

Etid klinik pou Kansè Ezofajyen nan Tucson, AZ

3 etid pou Kansè Ezofajyen ap chèche patisipan nan sit nan ak bò kote Tucson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Ap rekriteFaz 1/2
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927), Tucson
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05319730

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Ap rekriteFaz 1/2
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927), Tucson
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06445972

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Ap rekriteFaz 1/2
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 6927), Tucson
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06469944

Etid Kansè Ezofajyen nan lòt vil

Lòt etid nan Tucson

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.